RE: Pembrolizumab1 Jun 2025 10:15
"My comment: Hooray. It's bleeding obvious that Avacta will need to acquire more funds by the end of this year and there are many possibilities as to how that can be achieved. It is up to each individual to decide how to play this - buy low now, wait for a lower entry point or wait for a fundraiser, which will only be a good move if the raise price is lower than the current or later lower share price."
Well, it might be bleeding obvious to you now, but some here identified funding as the major issue some time ago. Your response, now you have caught up, is to proudly state how you filtered those views, so you arrive somewhat late to the party.
Its understandable that because AVCT are trying to do what they are, that it often here, becomes a very emotive subject.
My take (and I think the other few here) is that as this is a investment forum, that I specifically, can separate between their goals and whether or not this will be a successful investment.
I think this emotion can often overtake some posters here as you must realise too that AVCT is a commercial enterprise. They are not doing this work for free. The BoD if successful will likely become multi millionaires. If they fail, they will almost certainly go on to other jobs and still have a very very comfortable lifestyle. Investors here if it fails commercially, could potentially lose everything.
As a result It is not wrong, in my view, to look constantly at the risks involved.
As this is an evolving, developing company the risks and likely hood of various pathways move around continually, which is why the discussion here stays fairly vibrant.
It is a better BB imo, when the personalisation and the fruitless and futile guesses of what the "agenda's" of various posters are, stop and some actually try and answer the awkward questions, even if its to say something like "I don't know, and yes it is valid although i think your conclusions currently are too extreme"
I am the first to admit i don't what's going on either financially or scientifically. For me with my experience there are a number of "red flags" but at the same time there is to me, enough released data to realise that this stock has the potential to appreciate dramatically. So its a constant reassessment of risk reward, and always has been.
Pretty contentious, eh?